跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Approvals
/
TGA
/
XARELTO rivaroxaban 1 mg/mL granules for oral suspension bottle
Approved
STANDARD
XARELTO rivaroxaban 1 mg/mL granules for oral suspension bottle
Bayer Australia Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
Dec 9, 2025
Approval ID
b3838f213409fca7
Company
Bayer Australia Ltd
Type
Standard
Approval Details
Approval Id
b3838f213409fca7
Product Name
XARELTO rivaroxaban 1 mg/mL granules for oral suspension bottle
Artg Id
376019
Artg Name
XARELTO rivaroxaban 1 mg/mL granules for oral suspension bottle
Sponsor
Bayer Australia Ltd
Company Detail Path
/organization/bayer-australia-ltd
Artg Date
2022-09-12
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
Dec 9, 2025
Approval ID
b3838f213409fca7
Type
Standard
Back to TGA Approvals
XARELTO rivaroxaban 1 mg/mL granules for oral suspension bottle - TGA Drug Approval Details
